SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Q3 Trading Update

25 Oct 2018 07:00

RNS Number : 1088F
Elementis PLC
25 October 2018
 

Elementis plc

Q3 Trading Update

 Resilient overall performance, confident of continued progress in 2018

Elementis plc ("Elementis" or the "Group"), a global Specialty Chemicals Company, today issues its period end trading update for the three months ended 30 September 2018.

The Group has delivered resilient performance in the third quarter, and overall is on track and confident of making further financial and strategic progress in 2018.

Business Performance

· In Personal Care solid performance in the period was supported by growth in sales to direct customers of our unique, high margin hectorite based products and the successful delivery of SummitReheis synergies.

 

· In Coatings our transformation programme continues to gather pace as we optimise the product portfolio, implement efficiency measures and execute price increases. In Q3, performance in Europe and the Americas was similar to the first half but Asia has been impacted by weaker volumes and currency headwinds, primarily in China, as a result of an economic slowdown.

 

· Activity levels in Energy have improved driven by new business and early signs of recovery in deep water drilling. We continue to expect a sequential improvement in performance in the second half of the year.

 

· In Chromium, as previously communicated, production at Castle Hayne was temporarily suspended in September due to Hurricane Florence and subsequent flooding. Production has since restarted, and whilst we expect some mitigation from insurance, this outage will adversely impact Chromium full year operating performance. Otherwise, demand remains strong with supportive pricing momentum expected in 2019.

Mondo Minerals Acquisition

Completion of the Mondo Minerals acquisition on 23 October represents a material new growth opportunity for Elementis. In 2018 Mondo continues to trade in line with our expectations, and is experiencing good momentum going into 2019.

Strong cash generation

Elementis' strong free cash generation continued in Q3 and was enhanced by the disposal of our Jersey City site for $17m in August. Including the sale of the Surfactants business in February, this brings cumulative proceeds from asset disposals to over $60m in 2018.

Having completed the acquisition of Mondo Minerals, a material deleveraging profile is envisaged for the Group and this will be accelerated by the outcome of the triennial review of the UK pension scheme that concluded no cash top up payments are required from Elementis until at least 2021. This contrasts to the previous three years where total contributions were $32m.

 

Commenting on the performance, CEO, Paul Waterman said,

 

"Overall performance in the third quarter has been solid. We continue to implement our Reignite Growth strategy, focusing resources on higher margin growth opportunities, high grading our business portfolio and driving both cost and capital efficiency. In addition we are excited to begin the integration of Mondo Minerals at pace. "

 

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

Martin Robinson/David Allchurch, Tulchan Tel: 020 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTMIBLTMBATBAP
Date   Source Headline
2nd Aug 20227:00 amRNSHalf-year Report
1st Aug 202211:08 amRNSTotal Voting Rights
21st Jul 20223:14 pmRNSHolding(s) in Company
1st Jul 20229:47 amRNSTotal Voting Rights
20th Jun 20221:54 pmRNSHolding(s) in Company
17th Jun 20224:35 pmRNSPrice Monitoring Extension
3rd May 202210:27 amRNSTotal Voting Rights
3rd May 20227:00 amRNSCompany Secretary Change
26th Apr 202212:28 pmRNSResult of AGM
26th Apr 20227:00 amRNSAGM Trading Statement
5th Apr 20224:17 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:52 pmRNSAdditional Listing
22nd Mar 20224:18 pmRNSAnnual Financial Report & Notice of AGM
15th Mar 20227:53 amRNSDirectorate Change
8th Mar 202212:18 pmRNSDirector/PDMR Shareholding
8th Mar 202212:17 pmRNSDirector/PDMR Shareholding
8th Mar 202211:47 amRNSHolding(s) in Company
8th Mar 202210:43 amRNSDirector/PDMR Shareholding
8th Mar 202210:39 amRNSDirector/PDMR Shareholding
7th Mar 20223:26 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPreliminary results year ended 31 December 2021
1st Mar 20222:03 pmRNSDirector Declaration
1st Mar 202211:18 amRNSBlock listing Interim Review
18th Jan 20227:00 amRNSTrading Update
10th Jan 20221:20 pmRNSHolding(s) in Company
4th Jan 202211:48 amRNSTotal Voting Rights
1st Dec 202111:10 amRNSTotal Voting Rights
10th Nov 202112:20 pmRNSHolding(s) in Company
3rd Nov 202111:25 amRNSHolding(s) in Company
1st Nov 20211:44 pmRNSTotal Voting Rights
28th Oct 20217:00 amRNSQ3 Trading Update
19th Oct 20216:10 pmRNSDirector Declaration
5th Oct 20218:42 amRNSDirector Declaration
1st Sep 20219:49 amRNSBlock listing Interim Review
2nd Aug 202110:22 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSDirectorate Change
29th Jul 20217:00 amRNSHalf-year Report
5th Jul 202110:15 amRNSTotal Voting Rights
25th Jun 20212:59 pmRNSHolding(s) in Company
23rd Jun 20212:56 pmRNSDirector Declaration
1st Jun 202110:06 amRNSTotal Voting Rights
13th May 20213:39 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Statement
22nd Apr 20213:26 pmRNSAdditional Listing
20th Apr 20214:18 pmRNSResponse to Innospec Inc. announcement
20th Apr 20212:36 pmRNSPress Speculation Re Possible Offer for Elementis
9th Apr 20215:15 pmRNSAnnual Financial Report
7th Apr 20215:31 pmRNSDirector/PDMR Shareholding
1st Apr 20218:49 amRNSDirector/PDMR Shareholding
30th Mar 20214:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.